360 related articles for article (PubMed ID: 7664891)
1. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
Sutter G; Ohlmann M; Erfle V
FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
[TBL] [Abstract][Full Text] [Related]
2. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter G; Moss B
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression: effect of T7 RNA polymerase levels and alpha-amanitin.
Engleka KA; Lewis EW; Howard BH
Virology; 1998 Apr; 243(2):331-9. PubMed ID: 9568032
[TBL] [Abstract][Full Text] [Related]
4. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Wyatt LS; Moss B; Rozenblatt S
Virology; 1995 Jun; 210(1):202-5. PubMed ID: 7793072
[TBL] [Abstract][Full Text] [Related]
5. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.
Alexander WA; Moss B; Fuerst TR
J Virol; 1992 May; 66(5):2934-42. PubMed ID: 1560532
[TBL] [Abstract][Full Text] [Related]
6. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
7. Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors.
Kovacs GR; Parks CL; Vasilakis N; Udem SA
J Virol Methods; 2003 Jul; 111(1):29-36. PubMed ID: 12821194
[TBL] [Abstract][Full Text] [Related]
8. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
[TBL] [Abstract][Full Text] [Related]
9. Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal.
Huemer HP; Strobl B; Shida H; Czerny CP
J Virol Methods; 2000 Mar; 85(1-2):1-10. PubMed ID: 10716333
[TBL] [Abstract][Full Text] [Related]
10. A vaccinia virus MVA-T7-mediated recovery of infectious hepatitis A virus from full-size cDNA or from two cDNAs, both by themselves unable to complete the virus life cycle.
Kusov YY; Shatirishvili G; Klinger M; Gauss-Müller V
Virus Res; 2002 Oct; 89(1):75-88. PubMed ID: 12367752
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Fuerst TR; Niles EG; Studier FW; Moss B
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8122-6. PubMed ID: 3095828
[TBL] [Abstract][Full Text] [Related]
12. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
[TBL] [Abstract][Full Text] [Related]
13. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
14. Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system.
Elroy-Stein O; Moss B
Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.15. PubMed ID: 18429181
[TBL] [Abstract][Full Text] [Related]
15. Viable double vaccinia virus recombinants with the non-inducible phage T7 expression system.
Kriajevska MV; Zakharova LG; Altstein AD
J Gen Virol; 1993 Jan; 74 ( Pt 1)():47-53. PubMed ID: 8423450
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus-bacteriophage T7 expression vector for complementation analysis of late gene processes.
Eckert D; Merchlinsky M
J Gen Virol; 1999 Jun; 80 ( Pt 6)():1463-1469. PubMed ID: 10374964
[TBL] [Abstract][Full Text] [Related]
17. Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus.
Britton P; Green P; Kottier S; Mawditt KL; Penzes Z; Cavanagh D; Skinner MA
J Gen Virol; 1996 May; 77 ( Pt 5)():963-7. PubMed ID: 8609493
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector.
Ishii K; Ueda Y; Matsuo K; Matsuura Y; Kitamura T; Kato K; Izumi Y; Someya K; Ohsu T; Honda M; Miyamura T
Virology; 2002 Oct; 302(2):433-44. PubMed ID: 12441087
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
Sutter G; Ramsey-Ewing A; Rosales R; Moss B
J Virol; 1994 Jul; 68(7):4109-16. PubMed ID: 8207789
[TBL] [Abstract][Full Text] [Related]
20. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.
Hebben M; Brants J; Birck C; Samama JP; Wasylyk B; Spehner D; Pradeau K; Domi A; Moss B; Schultz P; Drillien R
Protein Expr Purif; 2007 Dec; 56(2):269-78. PubMed ID: 17892951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
